TrialJournal of viral hepatitis2026

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.

Qiumin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.